Biweekly News about the life science market! 19/01/2021
Brazil imported US$ 3.9 billion in chemicals in November, according to information from the Brazilian Chemical Industry Association (Abiquim), and the value represents increases of 10.5% compared to October this year and 10.6% compared to November 2019.
GlaxoSmithKline (GSK) and Vir Biotechnology have announced an agreement on the AGILE platform in the UK to assess, in a phase 1b/2a clinical trial, the use of VIR-7832 in patients with Covid-19 with mild and moderate symptoms.
The Butantan Institute, responsible for the production of coronavac vaccine in Brazil, must present, by February 28, remaining studies requested by the National Health Surveillance Agency (Anvisa) on the performance of the immunizer.
The difficulties in importing doses and insums to produce vaccines are a major threat to the Brazilian immunization campaign, which began the day before yesterday in São Paulo. For specialists, there is a real risk that vaccination against covid-19 will be stopped in a short time due to a total lack of immunizers.
Sign up for our Newsletter and be the first to know about the Life Science market!